Dr. Nancy Davidson, former VP Joe Biden and other cancer leaders share insights about disease that touches so many; Novel ‘barcode’ tracking of T cells in immunotherapy patients identifies likely cancer killers; and Fred Hutch/UW graduate student Qing Feng among this year’s 13 Weintraub award winners.
Tapscott’s global team discovers expression of an MD-causing gene thought to be inactive in humans; work may lead to new therapy targets, evolutionary insights
Nov. 1, 2010
| By Kristen Woodward
An international team of researchers led by the Fred Hutchinson Cancer Research Center’s Dr. Stephen Tapscott has made a second critical advance in determining the cause of a common form of muscular dystrophy known as facioscapulohumeral dystrophy, or FSHD.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.